Molecular Endocrinology, Vol 6, 1103-1112, Copyright © 1992 by Endocrine Society

ARTICLES

Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene highlights the functional importance of the second zinc finger of the androgen receptor in vivo

CA Quigley, BA Evans, JA Simental, KB Marschke, M Sar, DB Lubahn, P Davies, IA Hughes, EM Wilson and FS French
Department of Pediatrics, University of North Carolina, Chapel Hill 27599-7500.

Androgen-dependent gene transcription is mediated by the androgen receptor (AR) through interaction of its central zinc finger region with specific DNA sequences on target genes. Failure of this receptor- mediated gene transcription results in end organ resistance to androgens-the androgen insensitivity syndromes. In a pair of siblings with complete androgen insensitivity who had supranormal levels of androgen binding in genital skin fibroblasts, polymerase chain reaction and Southern blot analysis of the androgen receptor gene confirmed by polymerase chain reaction and sequence analysis of AR cDNA, revealed an in-frame deletion of exon C encoding the second zinc finger of the receptor. The mutant receptor in cultured genital skin fibroblasts had normal androgen binding affinity and was localized in the nucleus but had markedly reduced DNA-binding affinity. When recreated in vitro and tested in a cotransfection assay system the mutant receptor failed to activate transcription of an androgen-responsive reporter gene. This naturally occurring mutation highlights the functional dependence of the AR upon its second zinc finger in vivo and explains the complete insensitivity to androgen manifest by the affected individuals despite increased androgen binding. The elevated AR levels in the subjects' genital skin fibroblasts further suggests a possible role for the second zinc finger in autoregulation of receptor levels in vivo.

This article has been cited by other articles:

				R. Hu, T. A. Dunn, S. Wei, S. Isharwal, R. W. Veltri, E. Humphreys, M. Han, A. W. Partin, R. L. Vessella, W. B. Isaacs, et al. Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer Cancer Res., January 1, 2009; 69(1): 16 - 22. [Abstract] [Full Text] [PDF]

				S Kerkhofs, S Denayer, A Haelens, and F Claessens Androgen receptor knockout and knock-in mouse models J. Mol. Endocrinol., January 1, 2009; 42(1): 11 - 17. [Abstract] [Full Text] [PDF]

				K.A. Walters, C.M. Allan, and D.J. Handelsman Androgen Actions and the Ovary Biol Reprod, March 1, 2008; 78(3): 380 - 389. [Abstract] [Full Text] [PDF]

				K. A. Walters, C. M. Allan, M. Jimenez, P. R. Lim, R. A. Davey, J. D. Zajac, P. Illingworth, and D. J. Handelsman Female Mice Haploinsufficient for an Inactivated Androgen Receptor (AR) Exhibit Age-Dependent Defects That Resemble the AR Null Phenotype of Dysfunctional Late Follicle Development, Ovulation, and Fertility Endocrinology, August 1, 2007; 148(8): 3674 - 3684. [Abstract] [Full Text] [PDF]

				A J Notini, R A Davey, J F McManus, K L Bate, and J D Zajac Genomic actions of the androgen receptor are required for normal male sexual differentiation in a mouse model J. Mol. Endocrinol., December 1, 2005; 35(3): 547 - 555. [Abstract] [Full Text] [PDF]

				K. Ko, H. M. Theobald, R. W. Moore, and R. E. Peterson Evidence that Inhibited Prostatic Epithelial Bud Formation in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Exposed C57BL/6J Fetal Mice Is Not Due to Interruption of Androgen Signaling in the Urogenital Sinus Toxicol. Sci., June 1, 2004; 79(2): 360 - 369. [Abstract] [Full Text] [PDF]

				R. G. Erben, D. W. Soegiarto, K. Weber, U. Zeitz, M. Lieberherr, R. Gniadecki, G. Moller, J. Adamski, and R. Balling Deletion of Deoxyribonucleic Acid Binding Domain of the Vitamin D Receptor Abrogates Genomic and Nongenomic Functions of Vitamin D Mol. Endocrinol., July 1, 2002; 16(7): 1524 - 1537. [Abstract] [Full Text] [PDF]

				M. Burgos-Trinidad, G. L. Youngblood, M. R. Maroto, A. Scheller, D. M. Robins, and A. H. Payne Repression of cAMP-Induced Expression of The Mouse P450 17{{alpha}}-Hydroxylase/C17-20 Lyase Gene (Cyp17) by Androgens Mol. Endocrinol., January 1, 1997; 11(1): 87 - 96. [Abstract] [Full Text]